The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
INB-200: Phase 1 study of gene-modified autologous gamma-delta (?d) t cells in newly diagnosed glioblastoma multiforme (GBM) patients receiving maintenance temozolomide (TMZ).
 
Mina Lobbous
Consulting or Advisory Role - Alexion Pharmaceuticals; SpringWorks Therapeutics; Telix Pharmaceuticals
 
Lawrence Lamb
Employment - In8Bio Inc.
Leadership - In8Bio Inc.
Stock and Other Ownership Interests - In8Bio, Inc.
Patents, Royalties, Other Intellectual Property - IN8Bio, Inc.; University of Alabama Research Foundation
 
Kate Rochlin
Employment - In8Bio, Inc.
Leadership - IN8Bio, Inc.
Stock and Other Ownership Interests - IN8Bio, Inc.
Patents, Royalties, Other Intellectual Property - IN8Bio, Inc.
 
Thriumaine Pillay
No Relationships to Disclose
 
Mariska ter Haak
Employment - IN8Bio, Inc.
Stock and Other Ownership Interests - IN8Bio, Inc.
 
Louis Nabors
Consulting or Advisory Role - Anheart Therapeutics; Caldi; SERVIER
Patents, Royalties, Other Intellectual Property - Development of novel inhibitors to HuR through NCI funded peer reviewed research.
Travel, Accommodations, Expenses - SERVIER
Other Relationship - cns pharmaceuticals